Health panel wants to open ‘black box’ of drug brokers

Agency joins chorus seeking greater pricing transparency

A QUASI-INDEPENDENT state agency tasked with monitoring the health care marketplace has made a foray into the debate over pharmacy benefits managers, calling for more transparency about the role the companies play in setting the cost of drugs. Pharmacy benefits managers act as a broker between insurers or government on the one side, and drug(...)

Read More »